- Home
- XP vs FMS Comparison
XP vs FMS Comparison
Compare XP & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XP
- FMS
- Stock Information
- Founded
- XP 2001
- FMS 1996
- Country
- XP Cayman Islands
- FMS Germany
- Employees
- XP N/A
- FMS N/A
- Industry
- XP Investment Bankers/Brokers/Service
- FMS Misc Health and Biotechnology Services
- Sector
- XP Finance
- FMS Health Care
- Exchange
- XP Nasdaq
- FMS Nasdaq
- Market Cap
- XP 10.4B
- FMS 12.3B
- IPO Year
- XP 2019
- FMS 1996
- Fundamental
- Price
- XP $15.67
- FMS $21.80
- Analyst Decision
- XP Buy
- FMS Hold
- Analyst Count
- XP 7
- FMS 2
- Target Price
- XP $25.29
- FMS $23.00
- AVG Volume (30 Days)
- XP 3.4M
- FMS 312.5K
- Earning Date
- XP 11-19-2024
- FMS 11-05-2024
- Dividend Yield
- XP 9.34%
- FMS 2.94%
- EPS Growth
- XP 22.70
- FMS 46.47
- EPS
- XP 1.50
- FMS 2.50
- Revenue
- XP $2,917,751,972.00
- FMS $21,457,738,113.00
- Revenue This Year
- XP $27.03
- FMS $0.24
- Revenue Next Year
- XP $15.91
- FMS $3.41
- P/E Ratio
- XP $11.12
- FMS $17.13
- Revenue Growth
- XP 18.64
- FMS N/A
- 52 Week Low
- XP $15.24
- FMS $17.93
- 52 Week High
- XP $27.03
- FMS $22.76
- Technical
- Relative Strength Index (RSI)
- XP 31.60
- FMS 60.35
- Support Level
- XP $16.50
- FMS $21.80
- Resistance Level
- XP $17.11
- FMS $21.48
- Average True Range (ATR)
- XP 0.55
- FMS 0.30
- MACD
- XP -0.12
- FMS 0.13
- Stochastic Oscillator
- XP 9.31
- FMS 84.06
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.